CDK4/6

Pharma

Roche exec: Giredestrant may become company’s largest product

Despite a phase 3 flop in first-line breast cancer, Roche's pharma chief still thinks giredestrant could become the largest-selling product in its history.

Angus Liu Apr 23, 2026 2:52pm

ESMO: Eli Lilly looks to drive Verzenio adoption with survival win

Oct 17, 2025 8:00am

breast cancer ribbon Black woman health equity

Lilly answers Novartis breast cancer rivalry with survival win

Aug 27, 2025 10:59am

China approves 4 new drugs, including global 1st-in-class

Jul 2, 2025 11:32am

Novartis builds momentum with new drug launches

Apr 29, 2025 10:52am

Kisqali off to a 'very rapid' launch in early breast cancer: CEO

Jan 31, 2025 11:28am